Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A injection in glabellar muscles and its influence on forehead muscles
RBR-6dtzhdpPhase 4Recruiting
- Sponsor
- Uningá
- Start
- Mar 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of botulinum toxin type A in cutaneous aging and Facial dynamic wrinkles, sponsored by Uningá. Started Mar 2026; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
cutaneous agingFacial dynamic wrinkles
Beyond the preview
Go deeper on RBR-6dtzhdp.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6dtzhdp.